SCHEMBL12477609

SCHEMBL12477609

C[C@H](NOC1CCC1)C(=O)OP(=O)(O)Cl

nearest known ligand 0.34

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
ACE P12821 1/20 0.34
CA12 O43570 2/20 0.30
CA1 P00915 2/20 0.30
CA2 P00918 2/20 0.30
MMP2 P08253 2/20 0.30
CA9 Q16790 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12477242 0.97 CA12 (0.33) ACECA12CA1CA2MMP2
SCHEMBL12477720 0.95 MMP2 (0.36) ACECA12CA1CA2MMP2
SCHEMBL28646794 0.95 MMP2 (0.36) ACECA12CA1CA2MMP2
SCHEMBL27574167 0.84 MMP2 (0.35) ACECA12CA1CA2MMP2
SCHEMBL7027254 0.83 MMP2 (0.37) ACECA12CA1CA2MMP2
SCHEMBL28453622 0.81 TSHR (0.36) CA12CA1CA2MMP2CA9
SCHEMBL4268951 0.81 MMP2 (0.36) ACECA12CA1CA2MMP2
SCHEMBL4265150 0.81 MMP2 (0.36) ACECA12CA1CA2MMP2
SCHEMBL4266943 0.81 MMP2 (0.36) ACECA12CA1CA2MMP2
SCHEMBL12477861 0.78 SLC6A3 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2658857-B1 SUBSTITUTED PURINE NUCLEOSIDES, PHOSPHOROAMIDATE AND PHOSPHORODIAMIDATE DERIVATIVES FOR TREATMENT OF VIRAL INFECTIONS INHIBITEX INC (US) 2016-11-02 EP disclosed
EP-2658857-A2 SUBSTITUTED PURINE NUCLEOSIDES, PHOSPHOROAMIDATE AND PHOSPHORODIAMIDATE DERIVATIVES FOR TREATMENT OF VIRAL INFECTIONS Inhibitex, Inc. (US) 2013-11-06 EP disclosed
WO-2012092484-A2 SUBSTITUTED PURINE NUCLEOSIDES, PHOSPHOROAMIDATE AND PHOSPHORODIAMIDATE DERIVATIVES FOR TREATMENT OF VIRAL INFECTIONS INHIBITEX, INC. (US) 2012-07-05 WO disclosed